Long polar fimbriae 1 (Lpf1) of Escherichia coli O157:H7 is a tightly regulated adhesin, with H-NS silencing the transcriptional expression of the lpf1 operon while Ler (locus of enterocyte effacement-encoded regulator) acts as an antisilencer. We mapped the minimal regulatory region of lpf1 required for H-NS-and Ler-mediated regulation and found that it is 79% AT rich. Three putative sites for H-NS binding were identified. Two of them, named silencer regulatory sequence 1 (SRS1) and SRS2, are located on a region that covers both of the lpf1 promoters (P1 and P2). The third putative H-NS binding site is located within the lpfA1 gene in a region extending from ؉258 bp to ؉545 bp downstream of ATG; however, this site does not seem to play a role in lpfA1 regulation under the conditions tested in this work. Ler was also found to interact with Ler binding sites (LBSs). Ler binding site 1 (LBS1) and LBS2 are located upstream of the two promoters. LBS1 overlaps SRS1, while LBS3 overlaps the P1 promoter and SRS2. Based on the experimental data, we propose that H-NS silences lpf1 expression by binding to both of the SRSs on the promoter region, forming an SRS-H-NS complex that prevents RNA polymerase-mediated transcription. A model of the regulation of the lpfA1 operon of E. coli O157:H7 by H-NS and Ler is discussed.
Enterohemorrhagic Escherichia coli (EHEC) is an important intestinal pathogen and causative agent of diarrheal disease commonly associated with the consumption of contaminated food. The disease that occurs in humans ranges from uncomplicated diarrhea to hemorrhagic colitis and, in some cases, hemolytic uremic syndrome (21) . EHEC belongs to a group of pathogens that cause a histopathological lesion known as attaching and effacing (A/E), which is produced by the gene products encoded within a pathogenicity island termed LEE (locus of enterocyte effacement) (reviewed in references 15 and 21) .
Although it is well documented that the EHEC serotype O157:H7 ability to colonize the intestinal epithelia and cause A/E lesions is dependent on the expression of the LEE-encoded protein intimin, the presence of other adhesins on the surface of EHEC is also important for the colonization process (reviewed in reference 31). Analysis of sequenced genomes of different EHEC O157:H7 strains have revealed the presence of at least 23 loci encoding putative adhesins, with 10 of which corresponding to potential fimbrial adhesin gene clusters and 13 regions encoding nonfimbrial adhesins (13, 23) . We have shown that E. coli O157:H7 contains two nonidentical locusencoding homologues of the long polar fimbriae (Lpf), first described in Salmonella enterica serovar Typhimurium (reviewed in reference 31). The maximum expression of the E. coli O157:H7 lpf1 loci occurs in late exponential growth phase in tissue culture media at pH 6.5 and 37°C (30) . Expression of lpf1 has been shown to be driven by two putative sigma 70-dependent promoters (29) . We also demonstrated that the chromosomal lpfABCCЈDE fimbrial operon encodes Lpf1 and that the expression of the E. coli O157:H7 lpf1 in E. coli K-12 has been linked to increase adherence to tissue-cultured cells and is associated with the appearance of long, fine fimbrial structures (28) . Further, E. coli O157:H7 strains harboring mutations in one or both of the lpf loci have diminished colonization abilities in different animal models of infection (14, 30) and alter human intestinal tissue tropism (11) .
Ler (LEE-encoded regulator), a protein closely related to H-NS, is not only involved as a key factor for the A/E phenotype but also has a role as a positive regulator of virulence factors outside the LEE. The global regulatory effect of Ler includes genes such as espC in enteropathogenic E. coli (EPEC) or the EHEC virulence plasmid pO157-carried stcE gene (reviewed in reference 18). H-NS, a regulatory silencer protein, exerts a more global effect that extends to more than 400 genes, many of them involved in metabolism and pathogenesis (9, 12, 18) . In the case of lpf1, we reported that its expression is regulated by H-NS, presumably binding to the regulatory sequence upstream of lpfA1 and silencing its transcription, while Ler acts as an antisilencer, outcompeting the repression exerted by H-NS (28, 29) .
Analysis of the silencing/antisilencing mechanisms mediated by the H-NS and Ler proteins, for example, on the LEE2 and LEE3 divergent LEE-encoded operons in EPEC has revealed that H-NS represses expression by binding to two negative regulatory sequences denoted silencing regulatory sequence 1 (SRS1) and SRS2. These SRS regions flank the LEE2 and LEE3 promoters and generate a nucleoprotein repressor complex. Under conditions that induce LEE-encoded gene expression, Ler counteracts H-NS repression by preferentially binding to one of the silencers and displacing H-NS from it either by direct competition for its binding sites or by altering the local DNA architecture. This in turn disrupts the repressor complex and permits transcription of both promoters to proceed (2, 26) . Further, Haack and colleagues (12) have demonstrated that cis-acting DNA sequences are necessary for Ler binding at the LEE5 operon. LEE5 is also negatively regulated by H-NS, forming a nucleoprotein complex similar to that proposed for the LEE2-LEE3 operon. In this case, Ler binds to one side of the LEE5 operon, increasing transcription at both promoters and disrupting the repression exerted by the H-NS-DNA complex (12, 18) . Our prior studies have suggested that the regulatory control of the lpf1 operon could share similarities with the Ler-and H-NS-dependent mechanism controlling the expression of LEEencoded genes, perhaps following a strategy similar to that of the silencing/antisilencing of the LEE2 and LEE3 operons (2, 29) . Therefore, the aim of the present study was to investigate whether the regulation of the EHEC lpf1 operon requires binding of Ler and H-NS to AT-rich sequences and whether specific regions for binding can be identified in the vicinity of the promoter region or within the structural lpfA1 gene.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. Bacterial strains and plasmids used in this study are listed in Table 1 . Strains were routinely grown Gibco/Invitrogen) at 37°C. When required, antibiotics at the following concentrations were added to the media: ampicillin, 100 g/ml; tetracycline, 12.5 g/ml; kanamycin, 50 g/ml; and chloramphenicol, 30 g/ml. Construction of pK3-HNS. A SalI and SacI fragment containing the hns gene was obtained from plasmid pT3-HNS (2) and subcloned into the pMPM-K3 digested with the same restriction enzymes, generating plasmid pK3-HNS.
RNA isolation and cDNA synthesis. Bacterial cultures grown in LB broth were diluted in DMEM and grown at 37°C until they reached an optical density at 600 nm (OD 600 ) of approximately 1.2. Cultures were treated with RNAprotect reagent (Qiagen, Valencia, CA) to stabilize the RNA. Bacteria were harvested by centrifugation at 12,000 rpm for 15 min at 4°C and resuspended in RNeasy lysis buffer (Qiagen). RNA was purified in RNeasy columns (Qiagen), DNase treated (Ambion, Austin, TX), quantified, and qualitatively analyzed on agarose gels. A total of 5 g of total RNA was used for cDNA synthesis by employing the SuperScript first-strand synthesis system (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. A negative control with no reverse transcriptase was also included. The resulting cDNA was utilized for real-time quantitative reverse transcriptase PCR (qRT-PCR).
Phenotype complementation of mutant strains. To genetically complement the isogenic mutants, AC425 (hns::tet) and CB49 (ler::kan) were transformed with low-copy-number plasmids pK3-HNS and pT6Ler, respectively. For Ler expression using pT6Ler, EHEC strains were grown in DMEM at pH 7.2 at an OD 600 of up to 0.6, followed by the addition of L-(ϩ)-arabinose to a final concentration of 0.1%. Cultures were incubated until they reached an OD 600 of 1.2 before RNA was isolated.
Real-time qRT-PCR. Real-time quantitative RT-PCR was performed by using the SsoFast EvaGreen supermix, the CFX96 system test (Bio-Rad, Hercules, CA), and the primers listed in Table 2 . We used the rrsB gene to normalize the data, and a value of 1 was used to standardize lpfA1 expression in the wild-type strain. For each reaction, 1 l of reverse-transcribed cDNA was subjected to PCR amplification in a 25-l final volume containing 500 nM each primer and 12. for 30 min. To ensure the specificity of the PCR products, melting curve analysis was performed by heating products from 65°C to 95°C in increments of 0.5°C every 5 s while monitoring the fluorescence. These assays were performed at least in triplicate for each strain to obtain statistical data.
DNA manipulations. Standard methods were used to perform plasmid purification, PCR, and gel electrophoresis (25) . All oligonucleotides used are listed in Table 2 . Each PCR fragment was purified and concentrated using Microcon columns (Millipore), and the DNA concentration was calculated by observing the absorbance of samples at 260 nm.
Expression and purification of His-tagged H-NS and Ler proteins. The H-NSHis 6 or Ler-His 6 protein was expressed and purified as described previously (29) . Briefly, E. coli BL21/pLys21 harboring the pT6HNS or pT6Ler plasmid was grown to mid-logarithmic phase at 37°C. L-(ϩ)-Arabinose (Sigma-Aldrich, St. Louis, MO) was added to a final concentration of 0.1%, and the bacteria were further incubated for 4 h at 30°C. Cells were pelleted by centrifugation at 8,000 rpm for 10 min at 4°C, resuspended in 8 M urea buffer (pH 8.0), and disrupted by sonication. The cleared supernatant was applied to a HiTrap Ni 2ϩ -chelating column (Pro-Bond; Invitrogen). Proteins were eluted with a pH gradient (from pH 8.0 to 4.5) of 8 M urea buffer, and fractions containing purified H-NS-His 6 or Ler-His 6 were selected based on SDS-PAGE separation and Coomassie staining. The fractions were loaded onto membrane dialysis cassettes (Slide-ALyzer cassette with a molecular mass cutoff of 6,000 to 8,000 Da; Fisher, Pittsburgh, PA) and dialyzed at 4°C in buffer containing decreasing amounts of urea (4 M, 1 M, 0.2 M, and no urea). Aliquots of the purified proteins were stored at Ϫ80°C, and the protein concentration was determined using the Bradford protein assay.
EMSAs. Approximately 50 ng of PCR-generated DNA fragments corresponding to the different segments of the lpf1 promoter region and lpfA1 gene (fragments F1, F2, F3, F4, F5e, F6e, and F7e) was mixed with 150 nM (50 ng) or increasing concentrations of purified Ler-His 6 or H-NS-His 6 protein (solubilized in a buffer containing 0.4 M HEPES, 0.08 M MgCl 2 , 0.5 M KCl, 0.01 M dithiothreitol [DTT], 0.5% NP-40, and 1 mg/ml bovine serum albumin [BSA] ). The reaction mixtures were incubated for 20 min at room temperature and then separated by electrophoresis in a 6% polyacrylamide gel with Tris-borate-EDTA buffer at room temperature. The DNA bands were stained with ethidium bromide and visualized in a UV transilluminator. A fragment containing the ler promoter region from the LEE was used as a positive control, and 16S rRNA was used as a negative control.
DNase I footprinting assay. Oligonucleotides PLPFA258F ( 32 P labeled) and PLPFA129R and oligonucleotides 120F ( 32 P labeled) and 9R were used to amplify by PCR the lpf1 F1 and F4 regions, respectively. Labeled DNA fragments were incubated with increasing concentrations (150, 750, 1,000, and 1,500 nM) of purified Ler-His 6 and H-NS-His 6 in binding buffer (40 mM HEPES [pH 7.9], 50 mM KCl, 8 mM MgCl 2 , 1 mM dithiothreitol [DTT], and 1 mg/ml BSA) and 1 g of poly(dI-dC) and incubated at room temperature for 20 min. The reaction mixtures were then treated with 0.1 U of DNase I. Samples were resolved by electrophoresis in 8% polyacrylamide-8 M urea gels along with the corresponding sequencing ladder, which was generated with primers PLPFA258F and PLPFA120F, using pPLPFA as the template and the Sequenase version 2.0 DNA sequencing kit (USB, Cleveland, OH), according to the manufacturer's instructions.
RESULTS
H-NS and Ler are key regulators controlling lpf1 transcription. We have previously shown, using transcriptional gene fusions, that Ler and H-NS regulate the expression of the lpf1 operon (29) . To fully demonstrate that the regulatory effect of both H-NS and Ler occurs at the chromosomally carried lpf1 operon, real-time RT-PCR experiments were performed using total RNA obtained from the EHEC wild type (wt) and its isogenic ler and hns mutants grown under LEE-inducing conditions. Transcription of the lpfA1 gene was measured and normalized against a reference gene (e.g., rrsB), as described in Materials and Methods. We observed that expression of the lpfA1 gene in the hns mutant strain (AC425) increased by 3.9-fold with respect to that of the wt strain (P Ͻ 0.03). Complementation of the AC425 mutant with plasmid pK3-HNS restored H-NS repression of lpfA to wild-type levels (Fig. 1A) (P Ͻ 0.03). In contrast, expression of the lpfA1 gene in the ler mutant (strain CB49) resulted in approximately a 3-fold reduction with respect to that of the wild-type strain (Fig. 1B) (P Ͻ 0.001). Complementation of the EHEC ler mutant with plasmid pT6Ler restored lpfA1 expression to wild-type levels (Fig.  1B) . Our data confirmed the role of H-NS and Ler as regulators of the chromosomally carried lpf1 operon.
Ler and H-NS bind to defined DNA regions over the lpf1 promoter (lpfA1p). We have previously reported that the DNA sequence required for H-NS and Ler binding to the regulatory region of the lpf1 operon (29) consists of 271 bp, located between positions Ϫ262 and ϩ9, with respect to the start codon of the lpfA gene (lpfA1p 271 includes 262 bp of lpfA1p and 9 bp within the structural region of the lpfA1 gene). This AT-rich region (79%) contains multiple AT runs of up to 19 bp, a characteristic associated to H-NS DNA binding. To further map the regions that were required for H-NS-and Ler-specific binding, four fragments spanning the lpfA1p 271 sequence and three fragments located within the lpfA1 gene were used for electrophoretic mobility shift assays (EMSAs).
The EMSAs with different DNA fragments and purified Ler and H-NS proteins were performed using increasing concentrations from 0.04 to 150 nM (12.5 to 50 ng) of each protein and a fixed amount of lpfA1p fragments (150 nM [50 ng]) and amplified from the promoter region, as follows: F1 (129 bp), F2 (138 bp), and F4 (129 bp). We determined that the optimal protein concentration to achieve a shift in the DNA-protein complex was 150 nM (50 ng) (data not shown). Ler binds to the three promoter fragments, and more striking, Ler appeared to shift completely the free DNA of F2 and F4 fragments ( Fig.  2A, lanes 8 and 10) . Our results indicate that Ler preferentially binds to a region extending from Ϫ197 bp upstream of the ATG start codon to ϩ9 bp, including the two lpf promoters, which we have previously identified (29) . As a positive control, we used a 460-bp fragment amplified from the regulatory region of the EHEC ler gene (previously shown to bind Ler), and as a negative control, we used a 780-bp fragment from EHEC 16S rRNA (29) .
Similarly, EMSAs were also performed with 150 nM purified H-NS and the F1, F2, and F4 PCR fragments. The results indicate that H-NS binds to the 3 fragments from the lpfA1p sequence and shifts the entire free DNA from the F2 and F4 fragments, confirming that the promoter region is a (Fig. 2B) .
To further delineate the specific binding regions for these proteins, we amplified by PCR the F3 fragment (113 bp), which is identical to the F2 sequence, except for a 30-bp truncation at the 5Ј end (Fig. 4A) . When we examined the F3 fragment in the EMSA, Ler was no longer able to bind to this fragment, suggesting that a putative Ler binding site is located at the first 30 bp of F2 (Fig. 2C, lane 3) . In contrast, H-NS retains the ability to bind this fragment (Fig. 2C, lane 2) .
H-NS, but not Ler, is binding to a region within the lpfA1 gene. The in silico analysis of the lpfA1 sequence using MegAlign (DNASTAR, Madison, WI) and the Cn3D program (NCBI, Bethesda, MD) revealed that putative areas of curvature exist in some areas of the lpfA1 gene sequence due to the presence of high AT content segments (data not shown). Therefore, three DNA fragments (F5e, F6e, and F7e) were PCR amplified and used for EMSA analysis. We combined each DNA fragment with increasing amounts of the purified proteins, 37, 75, and 150 nM (12.5, 25, and 50 ng, respectively), and found that H-NS binds to the longest fragment (F7e) at a concentration of 25 ng, because the fragment changes mobility as the protein concentration increases (Fig. 3, lanes 11 and 12) . The F7e fragment extends from ϩ24 bp to ϩ545 in the lpfA1 gene (Fig.  4A) . In contrast, we did not observe any binding of the purified Ler protein to any of the three different DNA fragments located within the lpfA1 gene, which suggests to us that the regulatory effect exerted by this protein occurs only at the promoter region (data not shown).
Based on the information collected with the EMSA experiments, we began delimiting two putative Ler binding sites (LBSs). The first LBS spans from Ϫ197 bp to Ϫ167 bp upstream of the ATG start codon. The Ler protein also bound to the second LBS, which was mapped from Ϫ54 bp upstream of FIG. 5 . DNase I footprinting of Ler and H-NS on lpfA1p. (A) The 32 P-labeled fragments (F1 and F4) of the lpfA1 promoter were incubated in the absence or presence of increasing concentrations of Ler-His 6 protein (0, 150, 750, 1,000, and 1,500 nM). (B) Footprinting analysis with H-NS-His 6 was performed in the same manner as with the Ler protein and using the same protein concentrations. Lanes G, A, T, and C are the sequence ladders, and the protected areas are depicted as black boxes. To the right of both of the footprints, the DNA sequence of the lpfAp is depicted, and the protected DNA areas are represented by light gray (Ler-protected) and dark gray (H-NS-protected) bars. The Ϫ10 and Ϫ35 boxes, ribosome-binding sites (RBS), and transcriptional promoters are also illustrated.
the start codon to ϩ9 bp downstream within the lpfA1 gene, a region which was located in the F4 fragment. Similarly, we also identified the putative silencer regulatory sequence (SRS) in the promoter region. The SRS contains an H-NS binding site and is located between Ϫ197 bp upstream of the ATG to ϩ9 bp downstream within the lpfA1 gene. Because the H-NS protein bound to F7e, but not to the F5e or F6e fragments, an H-NS binding site, outside the regulatory region, was delimited from ϩ283 to ϩ545 bp in the lpfA1 gene (Fig. 4B) .
The H-NS and Ler binding sites overlap on the lpf1 promoter region. Our previous published data (29) showed that the promoter region is sufficient to control the expression of lpfA1 by Ler and H-NS, and the minimal region to interact with those proteins is approximately 271 bp. The EMSA results indicated that the LBS and SRS existed over the promoter region. To further characterize the LBSs and SRSs within the promoter region, DNase footprinting assays were performed as described in Material and Methods. DNA fragments F1 and F4, which cover the lpfAp 271 (Fig. 4A) , and increasing concentrations of Ler (0.15, 0.75, 1.0, and 1.5 M) were used, and the DNA sequences protected by Ler-His 6 were identified. The LBSs were remapped, and flanking regions were defined as follows: Ler binding site 1 (LBS1) is located between Ϫ220 and Ϫ193 bp, LBS2 from Ϫ177 to Ϫ170 bp, and LBS3 from Ϫ94 to Ϫ34 bp, upstream from the ATG codon. These LBSs delimited the specific interactions sites of Ler and corroborated the specificity of binding of this protein on lpfA1p (Fig. 4B and 5A) . A second set of DNase footprinting studies using different concentrations of H-NS-His 6 (0.15, 0.75, 1.0, and 1.5 M) were performed, and we delimited the following SRS sites on lpfA1p: SRS1 from Ϫ220 to Ϫ202 bp and SRS2 between Ϫ105 and Ϫ61 bp (Fig. 4B and 5B).
DISCUSSION
In the current study, we have shown that H-NS and Ler bind to define segments within the promoter region of lpfA1 (lpfA1p) and, apparently, within the lpfA1 gene to silence/ antisilence the expression of lpf1. In our previous studies, we found that these two regulatory proteins played an important role in the transcriptional control of lpf1 (29) , and now, we fully demonstrated that Ler and H-NS regulate the expression of the chromosomally carried lpf1 operon. Recent data from our laboratory have suggested that in the hns ler double mu- tant, an additional factor (most likely a positive regulator) is needed for lpf1 control, because lpfA1 expression increased significantly and the fold difference is more than the one observed in the hns or ler single mutants (our unpublished results). Interestingly, it has been reported that SlyA, a member of the MarR family of transcriptional regulators, works in Salmonella as an antirepressor only when H-NS is present (22) , but this does not seems to be the case in lpf1, because when we compared the hns mutant to the wild-type strain, maximal lpf1 expression is observed in the mutant strain. Further, the presence of another antirepressor protein counteracting H-NS function is unlikely, because in the absence of Ler, lpfA1 expression decreased significantly. Therefore, we are currently exploring the phenotype observed in the hns ler mutant to identify the additional regulatory factor controlling lpf1 expression in EHEC. Analysis of the minimal regulatory sequence required for lpf1 expression demonstrated characteristics found in those DNA sequences targeted by H-NS, for example, a high content of AT (79%) and evident DNA curvature. In bacteria such as EPEC and other enteric pathogens, H-NS is implicated in regulating the expression of horizontally acquired virulence genes with low percentages of GC (reviewed in references 5 and 27), and its main function is to participate as a negative FIG. 6 . Model of lpf1 expression mediated by the regulators H-NS and Ler. The silencing mechanism mediated by H-NS occurs by binding on the SRS1 and SRS2 sites, limiting the access of the RNA polymerase and preventing transcription initiation (steps I, II, and III). The antisilencing mechanism mediated by Ler counteracts the effect of H-NS and might be occurring in two ways, either by modifying the local DNA topology upon binding to specific sites and/or by competition with H-NS for target specific sequences and/or the promoters (step IV). These mechanisms are not mutually exclusive.
regulator, repressing transcription in response to changes in environmental signals, such as temperature and osmolarity (9, 32) . For example, H-NS represses transcription of the eltAB operon, encoding the heat-labile enterotoxin (LT) of enterotoxigenic E. coli (ETEC) by binding to two silencing regions located downstream of the eltAB promoter. Further in silico analysis also suggested that these sequences exhibit a high degree of DNA curvature (33) .
In EPEC, the divergently transcribed operons LEE2 and LEE3 have been shown to be regulated by H-NS/DNA interactions (2, 26) . It was shown that the promoter region possesses two silencer regulatory sequences (SRS1 and SRS2), and they are used for H-NS binding and repression of gene expression. It was also demonstrated that Ler can bind to and destabilize the H-NS/DNA complex, competing for the DNA and leading to an increase in expression from these operons. In EPEC and EHEC, H-NS can also regulate the expression of LEE5 and the escD-LEE4 operons (12, 20) , the bundle-forming pilus (bfp) genes and the perABC locus (only in EPEC) (24) , and the stcE gene (only in EHEC) (8) , and all of these genes are considered horizontally acquired genetic elements. However, the mechanism of regulation by H-NS in all of these models varies because this protein binds to minimal regions of ϳ10 bp located downstream, upstream, or within the promoter regions (1, 19) . It is believed that these sequences act in cis, interacting with H-NS and forming a nucleoprotein complex in the promoter region (6, 7, 10) .
Our efforts to map lpfA1p271 by footprinting analysis revealed that the H-NS protein has two specific silencing regulatory sequences in the promoter region, SRS1 and SRS2 (ϳ18 and 45 bp in length, respectively). SRS1 and SRS2 are 78% AT rich, and SRS2 overlaps the promoter at Ϫ83 bp from ATG. According to our previous data on lacZ gene reporter transcriptional fusions, we established that the promoter region is sufficient for the regulation by Ler and H-NS (29) . We have tested a transcriptional fusion, lacking SRS1, and observed that its expression is increased by 3-fold in the hns mutant compared to that of the wild-type strain, which suggests that SRS2 is still a functional sequence target for regulation by H-NS (our unpublished data). Interestingly, the presence of SRSs on lpfA1p suggests that the presumptive mechanism of regulation used is similar to those proposed in Vibrio cholerae ToxT and Salmonella enterica OmpS1 models, where H-NS binds to the promoter region, forming a transcriptional nucleorepressor filament (4, 34).
The repression mediated by H-NS is released by the antagonistic properties of antisilencers or positive transcription factors that either are acquired by horizontal gene transfer or are endogenous to the bacterial cell. The Ler protein, a horizontally acquired antisilencer, counteracts the effect of H-NS on the EPEC promoters of the grlRA, LEE2-LEE3, and LEE5 operons and in the EHEC lpf1 regulatory region (1, 2, 12, 29 ). In the current study, we found three Ler binding sites on lpfA1p, LBS1 (ϳ23 bp in length, overlapping SRS1), LBS2 (ϳ7 bp), and finally, LBS3 (ϳ 60 bp, overlapping SRS2). In LBS1 and LBS2 (separated from each other by ϳ16 bp) and LBS3, Ler binds, and it is likely that it modifies the local DNA topology and/or competes with H-NS to release lpfA1p, allowing the RNA polymerase to initiate transcription (Fig. 6) . It has been reported that as part of the positive regulation of individual genes and operons of the LEE pathogenicity island, the Ler protein increases the transcription of divergent LEE operons possessing both overlapping and nonoverlapping promoter regions, as in the case of the LEE2-LEE3 divergent operons and the grlRA operon, respectively (1, 26) . Furthermore, it has also been observed that Ler binds to AT-rich DNA regions, but no consensus sequence has been defined as the Ler binding site in the grlRA, LEE2-3, and LEE5 operons. These data suggest that Ler recognizes structural DNA motifs and not specific nucleotide sequences (2, 12) .
In support of our data, we are now proposing a model to explain the regulatory role of H-NS and Ler on lpf1. The silencer H-NS protein binds the lpfA1p in two defined regions (SRS1 and SRS2), and this protein shares these binding sites with Ler (Fig. 6) . A third putative SRS site in the lpfA1 gene has been located (Fig. 4B) ; however, the contribution of this region to the regulatory control of the lpf1 needs further study. Our model of regulation indicates that the target sequences facilitate H-NS binding on SRS1 and SRS2 (Fig. 6 , steps II and III), hiding or limiting the access of the RNA polymerase to the transcriptional start site. In our prior study (29) , we demonstrated that increasing concentrations of Ler are able to disrupt the H-NS/DNA complex, counteracting the silencing effect of H-NS. Binding of Ler to LBSs promotes changes in the DNA topology and/or competes through the shared DNA sequences with H-NS (Fig. 6, step IV) . This antisilencing Ler effect releases lpfA1p and permits transcription by the RNA polymerase. We are currently further improving this working model and are actively defining whether a relationship exists between SRS1, SRS2, and the third putative H-NS binding site located in the structural region of lpfA1 and whether they influence the regulatory control of the lpf1 operon.
